JP Morgan Call 52 LVS 21.06.2024/ DE000JB2UXB1 /
14/06/2024 08:39:14 | Chg.-0.001 | Bid14/06/2024 | Demandez à14/06/2024 | Sous-jacent | Prix d'exercice | Date d'expiration | Type d'option |
---|---|---|---|---|---|---|---|
0.001EUR | -50.00% | 0.001 Bid taille: 2,000 |
0.061 Ask la taille: 2,000 |
Las Vegas Sands Corp | 52.00 USD | 21/06/2024 | Call |
GlobeNewswire
09:11
Early Signals by WOO X: BTC Faces Downward Trend While TON Ecosystem Reaches New Highs with Surging ...
GlobeNewswire
09:01
Editas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients ...
GlobeNewswire
09:00
Beam Therapeutics Reports Data Highlighting Optimized Manufacturing Process for BEAM-101, an Investi...
GlobeNewswire
09:00
Editas Medicine Announces New Safety and Efficacy Data from the EdiTHAL Trial of Reni-cel in 7 Patie...
GlobeNewswire
09:00
Samsung Bioepis Presents Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimila...
GlobeNewswire
08:00
Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ T...
GlobeNewswire
07:00
Molecular Partners Presents Positive Preclinical Data for First Switch-DARPin Candidate MP0621 at EH...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page